Previous close | 0.9959 |
Open | 1.0300 |
Bid | 1.0000 x 4000 |
Ask | 1.1100 x 2900 |
Day's range | 0.9603 - 1.0600 |
52-week range | 0.8200 - 9.7000 |
Volume | |
Avg. volume | 1,808,317 |
Market cap | 91.493M |
Beta (5Y monthly) | 0.24 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.7200 |
Earnings date | 10 Aug 2022 - 15 Aug 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 6.00 |
NEW YORK, May 13, 2022--PAVmed and Lucid Diagnostics Chairman & CEO Lishan Aklog, M.D. named Top 50 Healthcare Technology CEO.
NEW YORK, May 12, 2022--PAVmed provides business update and preliminary first quarter 2022 financial results.
NEW YORK, May 11, 2022--Lucid Diagnostics provides business update and preliminary first quarter 2022 financial results.